Annual report
5592.TEDINET S100W451
Period2024-04-01 → 2025-03-31
Filed2025-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 134
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥8.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥7.4bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.5bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥1.4bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.9bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥939m | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥816m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.7bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥871m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥391m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥516m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥874m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥12.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥23.1bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥12.2bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥11.0bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.6bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥16.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.4bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.8bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥3.0bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.6bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.1bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.6bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.0bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥5.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.1bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.7bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.5bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥541m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥5.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥7.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥635m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥565m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥184.89 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.48 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.64 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.82 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥180.63 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥84 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥753.05 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥579.97 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥293.47 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥266.8 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 69.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.6% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.0% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.2% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 27.5% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 19.2% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.2% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 30.7% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 484 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 505 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 424 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 396 | at 2022-03-31d | Cons. | Number of employees |
| Revenue | ¥7.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥6.5bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥5.7bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.6bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.2bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥1.0bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥956m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥688m | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥426m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥374m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥860m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥970m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.6bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥652m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥399m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥332m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥652m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥11.9bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥22.2bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥11.7bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥10.0bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥14.7bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥4.1bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥16.1bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥7.8bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥6.1bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.6bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥2.2bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥869m | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.5bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥13.8bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥141.21 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.73 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.44 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.73 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28,798.13 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥137.95 | 2024-04-01 → 2025-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥62.87 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥27 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥693.21 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥554.26 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥285.27 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥241.82 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥35,264.26 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 65.3% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.4% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.5% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 5.9% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 22.4% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.0% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.5% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 21.5% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 188.6% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 11,223,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,980,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,180,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 30,600 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,600 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 322 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 315 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 320 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 303 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 252 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 1,331
| Item | Context | Value | Unit |
|---|---|---|---|
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding amount of contract liabilities (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding financial covenant (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding gain on sales of shares of subsidiaries text block (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on disposal of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on sale of subsidiary company text block (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments income taxes and tax effects relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities of consolidated subsidiary acquired by purchase of shares during reporting period (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities of consolidated subsidiary disposed of by sales of shares during reporting period (text) | CurrentYearDuration | Text · Plus | |
| Notes leases consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes retirement benefits consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes business combinations consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes real estate for lease etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | CurrentYearDuration | Original text (Japanese)当社グループは薬局、医療向けソリューションの開発および販売の単一セグメントであるため、記載を省略しております。 | |
| Information for each product or service (text) | Prior1YearDuration | Text · Plus | |
| Revenues from external customers information for each region (text) | Prior1YearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | Prior1YearDuration | Text · Plus | |
| Information for each of main customers (text) | Prior1YearDuration | Text · Plus | |
| Information for each product or service (text) | CurrentYearDuration | Text · Plus | |
| Revenues from external customers information for each region (text) | CurrentYearDuration | Text · Plus | |
| Property plant and equipment information for each region (text) | CurrentYearDuration | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration | Text · Plus | |
| Description of factors which led to recognition of gain on bargain purchase (text) | CurrentYearDuration | Text · Plus | |
| Notes related parties consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes per share information consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of corporate bonds (text) | CurrentYearDuration | Text · Plus | |
| Annexed consolidated detailed schedule of borrowings (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |